Every 10-Q that Enovix Corporation (ENVX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ENVX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ENVX filings page.
Enovix Corporation reported higher revenue but continued losses for the fiscal quarter and year-to-date ended July 5, 2026. Quarterly revenue rose to $9.0 million from $7.5 million, and year-to-date revenue increased to $16.6 million from $12.6 million, driven mainly by defense and industrial customers. Gross profit was modest at $1.3 million for the quarter.
The company recorded a quarterly net loss of $43.1 million and a year-to-date net loss of $81.3 million, with higher interest expense from $532.8 million of convertible debt contributing to results. Operating expenses remained high, with year-to-date R&D at $51.0 million and SG&A at $39.1 million, though R&D declined versus the prior year period.
Enovix ended the quarter with $552.1 million in cash, cash equivalents, restricted cash, and investments and working capital of $453.6 million, and expects these resources to meet funding needs for at least the next twelve months. Management highlights progress in smartphone qualification, initial smart eyewear shipments under a 50,000-pack order, a growing $183 million drone/defense pipeline, and ongoing efforts to improve manufacturing yields and scale its lithium-ion and silicon-anode battery platforms.
Enovix Corporation reported another quarterly loss while growing revenue as it scales advanced lithium-ion battery production. For the fiscal quarter ended April 5, 2026, revenue rose to $7.6 million from $5.1 million a year earlier, driven mainly by defense, industrial and consumer electronics shipments from South Korea.
Gross profit improved to $1.6 million, a margin of about 20%, but heavy research and development and selling, general and administrative spending kept the business unprofitable. Net loss widened to $38.3 million compared with $23.5 million in the prior-year quarter as interest expense increased following additional convertible note issuance.
Enovix ended the quarter with $582.7 million in cash, cash equivalents and investments and working capital of $507.6 million, and it expects this liquidity to cover funding needs for at least the next 12 months while it ramps its Fab2 facility in Malaysia and advances AI-focused and defense-oriented battery products.
Enovix reported Q3 2025 results, showing revenue of $7.99 million and a gross profit of $1.40 million. Operating loss was $46.97 million, and net loss was $53.71 million. Year‑to‑date revenue reached $20.56 million with a net loss of $121.75 million.
Liquidity strengthened during the quarter: cash and cash equivalents were $335.50 million, with short‑term investments of $223.32 million and long‑term investments of $89.45 million. The company issued $360.0 million of 2030 convertible senior notes and purchased capped calls for $45.29 million. Warrant exercises generated $232.11 million in gross proceeds, and Enovix repurchased 5,437,556 shares for $58.39 million.
Total assets were $913.71 million and long‑term debt, net, was $518.35 million. Shares outstanding were 215,816,004 as of November 3, 2025. Management states current cash, cash equivalents and investments are expected to meet anticipated needs for at least the next twelve months.